期刊文献+

贝那普利对慢性充血性心力衰竭患者血管内皮舒张功能的影响 被引量:5

Influence of Benazepril on vascular endothelial dilatation function of chronic congestive heart failure patients
下载PDF
导出
摘要 目的:探讨贝那普利对慢性充血性心力衰竭患者血管内皮舒张功能的影响。方法:将2008年1月~2009年10月我院收治的慢性充血性心力衰竭患者286例随机分为两组,常规治疗组146例采用常规治疗,贝那普利组140例采用常规治疗联合贝那普利治疗,观察两组的疗效及肱动脉流量介导性舒张(FMD)值。结果:两组治疗前FMD比较,无显著性差异(P>0.05);两组治疗后FMD比较,有显著性差异(P<0.05)。结论:贝那普利对改善血管内皮舒张功能有着良好的临床效果,并且应用方便,副作用小,促进慢性充血性心力衰竭患者疾病的康复,改善患者的生活质量。 Objective: To study the influenle of Benazepril on vascular endothelial dilatation function of chronic congestive heart failure patients. Methods: From January 2008 to October 2009 in our hospital, 286 cases of chronic congestive heart failure patients were randomly divided into two groups, 146 cases of conventional treatment group with conventional therapy; 140 patients of Benazepfil group with conventional combined Benazepril, the efficacy and flow-mediated dilation (FMD) of two groups were observed. Results: Before treatment, there was no significant difference in FMD of two groups (P〉0.05). After treatment, there were significant difference in FMD of two groups (P〈0.05). Conclusion: Benazepril has good clinical results on vascular endothelial dilatation function, and application convenience, less side effect, it can promote the convalescence of chronic congestive heart failure patients, improve the life quality of patients.
作者 王智彬
出处 《中国医药导报》 CAS 2010年第25期45-46,共2页 China Medical Herald
关键词 贝那普利 慢性充血性心力衰竭 血管内皮舒张功能 影响 Benazepril Chronic congestive heart failure Vascular endothelial function Influence
  • 相关文献

参考文献5

二级参考文献80

共引文献165

同被引文献44

  • 1张国民,杨树森.应用超敏C-反应蛋白研究他汀药物联合血管紧张素转换酶抑制剂对急性冠状动脉综合征的干预作用[J].内科急危重症杂志,2005,11(2):80-81. 被引量:4
  • 2熊晨晖.贝那普利与单硝酸异山梨酯联用治疗慢性肺心病心力衰竭疗效观察[J].中国医药导报,2007,4(08S):61-61. 被引量:3
  • 3Mann DL. Recent insights into therole of tumor necrosis factor in the failure heart[J]. Heart Fail Rev ,2001,6( 1 ):71-80.
  • 4Haeling SV, Anker SD,Bassenge E. Statins and therole of nitricoxide in chronic heart failure[J]. Heart Fail Rev, 2003,8 ( 1 ) : 99-106.
  • 5Thakur NK,Hayashi T,Surni D,et al. HMG-CoA reductase inhibitor stabilizes rabbit atheroma by increasing basal NO and decreasing superoxide[J]. Am J Physiol, 2001,281 ( 1 ) :75-83.
  • 6Maack C,KartesT,Kiher H,et al. Oxygen free radical release in human failing myocardium is associated with increased activity of raclGTPase and represents a target for statin treatment[J]. Circulation ,2003,108 (13) : 1567-1574.
  • 7Patel R, Nagueh SH ,Tsybouleva N ,et al. Simvas tatin induces regression of cardiac hypertrophy and fibrosis and improves cardiac function in atransgenic rabbit model of human hypertrophic ardiomyopathy[J]. Circu- lation ,2001,104( 1 ) :317.
  • 8Dechend R,Fiebeler A,Park JK,et al. Amelioration of angiotension II induced injury by a 3-hydroxy-3-methyglutaryl coenzyme a reindnctase inhibitor[J]. Circulation,2001,104(5) :576-581.
  • 9Luan Z,Chase AJ,Newby AC~ Statins inhibit secretion of metalloproteinases- 1 ,-2,-3,and -9 from vascular smooth muscle cells and macrophages[J]. Arterioscler Thromb Vasc Biol,2003,23 (5) : 769-775.
  • 10Ogata Y,Takahashi M ,Takeuchi K,et al. Fluvastat in induces apoptosisin rat neonatal cardiacmyocyte:a possible mechanism of statin-mtenuated cardiac hypertrophy[J]. J Cardiovasc Pharmacol,2002,40 (6) : 907-915.

引证文献5

二级引证文献27

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部